Sergio Martínez-Yélamos

14PUBLICATIONS
77CO-AUTHORS
Central nervous systemNeurology and neuromuscular diseasesMedical bacteriologyTō te Māori mātauranga hangarau, mātauranga atu anō, mātauranga haere tonu, me te mātauranga hapori (Māori technical, further, continuing and community education)Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 22, 2026
Serum biomarkers remain stable after transitioning from intravenous to subcutaneous natalizumab in multiple sclerosis.

|Mar 04, 2026
Proteomic profile of CSF obtained at the time of diagnosis determines amyotrophic lateral sclerosis progression and survival: CXCL7 levels in disease prognosis and survival.

Sergio Roca-Pereira, Yaiza López-Sampere, Pol Mengod-Soler

|Nov 05, 2025
Benign multiple sclerosis and long-term outcomes after 30 years.

E Matas, L Bau, L Romero-Pinel

|Oct 03, 2025
3D T1 turbo spin echo improves detection of gadolinium-enhancing multiple-sclerosis lesions.

Pablo Naval-Baudin, William F Bermúdez Bravo, Vanessa I Pineda-Borja

|Aug 08, 2025
Authors' response to comment on "Second-line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin, and baclofen".

Albert Muñoz-Vendrell, Paloma Valín-Villanueva, Raquel Tena-Cucala

|May 09, 2025
Second-line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin and baclofen.

Albert Muñoz-Vendrell, Paloma Valín-Villanueva, Raquel Tena-Cucala

Pageof 3

Frequent Collaborators

7 joint publications

Albert Muñoz-Vendrell

6 joint publications

Antonio Martínez-Yélamos

5 joint publications

Lucía Romero-Pinel

5 joint publications

Pablo Arroyo-Pereiro